Aayush Wellness Appoints M/s. A. Raghavendra Rao & Associates

1 min read     Updated on 21 May 2026, 04:04 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Aayush Wellness Limited has appointed M/s. A. Raghavendra Rao & Associates as its statutory auditors to fill a casual vacancy, subject to shareholder approval. The firm, established in 1986, holds FRN 003324S and will hold office until the conclusion of the ensuing Annual General Meeting.

powered bylight_fuzz_icon
40904889

*this image is generated using AI for illustrative purposes only.

Aayush Wellness Limited has appointed M/s. A. Raghavendra Rao & Associates as its statutory auditors to fill a casual vacancy caused by the resignation of the previous auditor. The Board of Directors approved the appointment at its meeting held on May 21, 2026, based on the recommendation of the Audit Committee.

The new auditors, M/s. A. Raghavendra Rao & Associates, Chartered Accountants, hold Firm Registration Number (FRN) 003324S and Practicing Certificate (PRC) No. 018363. The firm was established in 1986 and offers audit, taxation, accounting, and advisory services across various sectors in India.

Appointment Details

The appointment is subject to the approval of the shareholders of the Company. The auditors will hold office until the conclusion of the ensuing Annual General Meeting. Shareholders must approve the appointment within three months from the date of the Board's recommendation.

Particulars Details
Name of Statutory Auditors M/s. A. Raghavendra Rao & Associates, Chartered Accountants
Reason for Change To fill casual vacancy caused by resignation of M/s. A J M S & Co. LLP
Date of Appointment May 21, 2026
Tenure Till the conclusion of the ensuing Annual General Meeting

Auditor Profile

M/s. A. Raghavendra Rao & Associates is a partnership firm with extensive experience in statutory audits, internal audits, tax audits, and bank audits. The firm serves clients across industries such as banking, financial services, manufacturing, healthcare, information technology, and real estate. There are no reported relationships between the directors of Aayush Wellness Limited and the newly appointed auditors.

Historical Stock Returns for Aayush Wellness

1 Day5 Days1 Month6 Months1 Year5 Years
+0.03%-6.28%-4.37%-6.15%-72.70%+1,520.30%

What were the specific reasons behind M/s. A J M S & Co. LLP's resignation, and could they signal underlying financial or governance concerns at Aayush Wellness Limited?

How might the auditor transition impact the timeline and reliability of Aayush Wellness Limited's upcoming financial disclosures or annual report?

Will shareholders raise concerns or potentially reject the appointment of M/s. A. Raghavendra Rao & Associates at the ensuing Annual General Meeting, given the abrupt auditor change?

Aayush Wellness Enters India's ₹366.56 Billion Metabolic Health Market with Launch of Aayush Dia Shield Tablets

2 min read     Updated on 08 May 2026, 11:41 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Aayush Wellness Limited launched Aayush Dia Shield Tablets on May 08, 2026, entering India's ₹366.56 billion metabolic health market under Regulation 30 of SEBI regulations. The product targets over 230 million Indians affected by diabetes or pre-diabetes, with over 100 million living with diabetes and 136 million classified as pre-diabetic. Formulated with herbal extracts including Fenugreek, Karela, Gymnema sylvestre, and Cinnamon Bark Extract, the tablets are positioned as a science-backed preventive wellness solution for long-term blood sugar management.

powered bylight_fuzz_icon
39766260

*this image is generated using AI for illustrative purposes only.

Aayush Wellness Limited, an integrated healthcare and preventive wellness company, has announced the launch of Aayush Dia Shield Tablets, marking its strategic entry into India's diabetes and metabolic health sector. The announcement was made under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, on May 08, 2026. The product is a science-backed dietary supplement designed to address the escalating metabolic health challenge in India, where over 230 million individuals are currently affected by diabetes or pre-diabetes.

Addressing a National Health Priority

India is currently grappling with a significant metabolic health burden, with over 100 million people living with diabetes and an additional 136 million classified as pre-diabetic. Notably, nearly 50% of cases remain undiagnosed, and the prevalence is rising sharply among working professionals aged 30–45. Aayush Dia Shield Tablets are formulated to provide a preventive and supportive solution for long-term blood sugar management, catering to an increasingly health-conscious population.

Parameter: Details
Total Affected Population: Over 230 million Indians
Diabetic Population: Over 100 million
Pre-Diabetic Population: 136 million
Undiagnosed Cases: Nearly 50%
High-Risk Age Group: Working professionals aged 30–45

Science-Backed Botanical Formulation

Aayush Dia Shield Tablets feature a blend of time-tested herbal extracts specifically chosen for their metabolic benefits. The formulation draws on established botanical ingredients to support blood sugar management and overall metabolic wellness.

  • Trigonella foenum-graecum (Fenugreek/Methi): Enhances insulin response and sugar control.
  • Momordica charantia (Karela): Naturally supports lower blood sugar levels and bowel regularity.
  • Gymnema sylvestre (Gurmar): Assists in reducing sugar absorption and cutting cravings.
  • Cinnamon Bark Extract: Enhances digestion and improves glucose utilization.

Key Benefits of Aayush Dia Shield Tablets

The product is positioned as a comprehensive wellness supplement with multiple functional benefits:

  • Metabolic Support: Promotes efficient glucose metabolism and energy utilization.
  • Antioxidant Defense: Combats oxidative stress linked to lifestyle-related imbalances.
  • Holistic Vitality: Supports digestive health, nutrient absorption, and overall daily wellness.
  • Overall Wellness: A comprehensive supplement aimed at long-term metabolic and lifestyle health support.

Strategic Market Positioning

The launch positions Aayush Wellness within the high-growth ₹366.56 billion metabolic health market. As a nutraceutical product, Aayush Dia Shield Tablets are designed for modern lifestyles, offering a convenient daily format that fosters repeat-consumption behavior. Managing Director Naveena Kumar commented on the launch: "India's diabetes challenge represents both a major public health priority and a significant wellness opportunity. With Aayush Dia Shield Tablets, we are strengthening our preventive healthcare portfolio with a solution aligned to evolving consumer needs and our long-term growth strategy."

About Aayush Wellness Limited

Aayush Wellness Limited, established in 1984, is an ISO 9000 and ISO 22000 certified company and a pioneering name in health and wellness solutions. The company is dedicated to offering products that merge wellbeing with innovation and is committed to promoting healthier lifestyle choices through its diverse range of wellness products and services.

Historical Stock Returns for Aayush Wellness

1 Day5 Days1 Month6 Months1 Year5 Years
+0.03%-6.28%-4.37%-6.15%-72.70%+1,520.30%

How will Aayush Wellness differentiate Dia Shield Tablets from established Ayurvedic diabetes supplements like Himalaya and Dabur in an increasingly competitive nutraceutical market?

Could the rising prevalence of diabetes among working professionals aged 30–45 prompt Aayush Wellness to pursue corporate wellness partnerships or B2B distribution channels?

What regulatory pathway challenges might Aayush Dia Shield Tablets face as FSSAI tightens oversight on health claims made by nutraceutical and dietary supplement brands in India?

More News on Aayush Wellness

1 Year Returns:-72.70%